CRISTINA DEPALMA: Open Payments
NPI 1760841233 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 48 payments from 14 companies in 2025. Trend: 2023 $491 · 2024 $1,248 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 3 | $226 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $184 |
| Collegium Pharmaceutical, Inc. | 10 | $154 |
| Corcept Therapeutics | 7 | $106 |
| Forte Bio-Pharma LLC | 3 | $45 |
| Abbott Laboratories | 2 | $42 |
| Globus Medical, Inc. | 1 | $34 |
| TOLMAR, INC. | 2 | $34 |
| Lilly USA, LLC | 2 | $33 |
| Antares Pharma, Inc. | 1 | $18 |
Products named: QUTENZA, RELISTOR, Belbuca, Korlym, PROLATE, Senza, JATENZO, MOUNJARO.
Industry payments across NJ — which companies pay providers there.
